Wolverine Trading
SPRY icon

Wolverine Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Wolverine Trading’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$236K Buy
+24,266
New +$348K ﹤0.01% 4715
2025
Q1 		– Sell
-20,763
Closed -$221K – 5754
2024
Q4 		$221K Buy
20,763
+1,018
+5% +$14.3K ﹤0.01% 4401
2024
Q3 		$283K Buy
19,745
+9,038
+84% +$108K ﹤0.01% 3695
2024
Q2 		$91.1K Buy
+10,707
New +$95K ﹤0.01% 4090

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wolverine Trading's SPRY Position: Q3 2025 in Review

Wolverine Trading opened a new position in ARS Pharmaceuticals (SPRY) in Q3 2025: 24,266 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #4715 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in SPRY as recently as Q4 2024.

Wolverine Trading first reported a position in SPRY in Q2 2024 and has held it in 4 quarters since. The position peaked at $283K in Q3 2024. 188 funds tracked by Wall St. Rank hold SPRY as of Q3 2025.

  • Wolverine Trading held 24,266 shares of ARS Pharmaceuticals worth $236K as of Q3 2025.
  • ARS Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
  • ARS Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4715 holding.
  • Wolverine Trading first reported a position in ARS Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Wolverine Trading's ARS Pharmaceuticals position peaked at $283K in Q3 2024.
  • 188 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.